ParkCell’s  goal is to be able to provide cell transplantation based treatment services for patients suffering from Parkinson’s Disease. Potentially, this method could eventually present a cure for many PD patients.

We can offer the whole treatment package in our own facility or deliver our cells-based product to any other clinic to be used in your own setting.

Our cell-based systems can also be used for the discovery and development of neuroprotective substances to halt PD in an early stage and biomarkers in Parkinson’s disease.

Feel free to contact us for further information about how we can work together

Therefore, ParkCell is performing cutting edge pre-clinical and clinical research and development in the following areas:

  • Generation of cells for transplantation in Parkinson’s disease
  • GMP grade cell culture protocols
  • Clinical transplantation methods and protocols
  • Cell-based biomarker discovery